Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Mucositis 1 Esophagitis 1 Breast Neoplasms 1

Interventions

Tamoxifen 10 Capecitabine 10 Trastuzumab 9 Docetaxel 9 pyrotinib 7 Exercise 7 Control Groups 7 Vinorelbine 6 Paclitaxel 6 Letrozole 6 Gemcitabine 6 Cyclophosphamide 6 Carboplatin 6 exemestane 5 Indocyanine Green 5 Anastrozole 5 pertuzumab 4 dalpiciclib 4 Injections 4 Fulvestrant 4 Doxorubicin 4 Surgical Procedures, Operative 3 Standard of Care 3 Radiotherapy 3 Radiation 3 Mammography 3 Epirubicin 3 Drug Therapy 3 Cisplatin 3 Bevacizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Alginates × Breast × Clear all

NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡